Diabetes Mellitus Clinical Trial
Official title:
Pulmonary Effects of Diabetes Mellitus in Anesthetized Mechanically Ventilated Patients
Type 2 diabetes mellitus (T2DM) poses a significant burden on the patients and the health
care system. The increasing number of surgery performed in elderly population results in an
increased number of perioperative T2DM-related adverse effects. T2DM has a prevalence of
30-40% in a population undergoing cardiovascular surgery. Cardiac surgery, especially
cardiopulmonary bypass (CPB) is also known to deteriorate respiratory mechanics. The vascular
effects of T2DM are well characterized, however, its effects on the mechanical properties of
the respiratory system or the exhaled carbon-dioxide concentration curve (capnogram) during
and following CPB are yet to be fully discovered.
Therefore, the study is aimed at characterizing the respiratory consequences of T2DM, i.e.:
i: deteriorations of airway function that might be a result of smooth muscle dysfunction; ii:
deterioration of the viscoelastic properties of the lung as a result of lung volume loss or
structural changes, iii: exploring whether the changes of respiratory mechanics caused by
cardiac surgery exhibit a different time course in T2DM and control patients.
The study also aims at characterizing the effects of T2DM on capnogram parameters: i: whether
it influences capnogram shape factors, ii: whether any differences can be detected in the
dead-space parameters and iii: whether cardiac surgery has a different effect on capnogram
parameters in T2DM patients compared to controls.
One hour before the surgery, patients are premedicated with lorazepam (per os, 2.5 mg).
Induction of anaesthesia is achieved by iv midazolam (30 μg/kg), sufentanyl (0.4-0.5 μg/kg),
and propofol (0.3-0.5 mg/kg), and iv propofol (50 mg/kg/min) is administered to maintain
anaesthesia. Intravenous boluses of rocuronium (0.6 mg/kg for induction and 0.2 mg/kg every
30 minutes for maintenance) is administered iv to ensure neuromuscular blockade. A cuffed
tracheal tube (internal diameter of 7, 8, or 9 mm) is used for tracheal intubation, and
patients are mechanically ventilated (Dräger Zeus, Lübeck, Germany) in volume-controlled mode
with decelerating flow. A tidal volume of 7 ml/kg and a positive end-expiratory pressure of 4
cmH2O are applied, and the ventilation frequency is adjusted to 12-14 breaths/min to maintain
end-tidal CO2 partial pressure of 36 38 mmHg. Mechanical ventilation is performed with a
fraction of inspired oxygen of 0.5 before CPB, and it is increased to 0.8 after CPB. As a
standard part of the cardiac anaesthesia procedure, oesophageal and rectal temperature probes
are introduced, and a central venous line is inserted into the right jugular vein. The left
radial artery is also cannulated to monitor systolic, diastolic and mean arterial (MAP) blood
pressures and arterial blood gas samples.
The membrane oxygenator is primed with 1,500 ml lactated Ringer's solution prior to CPB.
Intravenous heparin (300 U/kg) is injected into the patient, to achieve an activated clotting
time of 400 s during CPB procedures. During CPB, mild hypothermia is allowed, the mechanical
ventilation is stopped, and the ventilator is disconnected without applying positive airway
pressure. Before restoring ventilation, the lungs are inflated 3-5 times to a peak airway
pressure of 30 cmH2O to facilitate lung recruitment.
A flow meter and a mainstream capnometer is to be inserted into the breathing circuit between
the endotracheal tube and the Y-piece of the breathing circuit to record capnogram curves. a
T-piece with 2 collapsible segments is attached to the distal tracheal tube, with one end
connected to the respirator and the other end to a loudspeaker-in-box system (FOT system) to
measure respiratory mechanics by the use of forced oscillations. During normal ventilation
the FOT system is not communicating with the patient, however, during measurements of
respiratory mechanics the ventilator is to be stopped at end-expiration and the breathing
circuit is blocked in a way that allows a connection between the FOT system and the patient.
During a 15-s long apnoeic period respiratory mechanical parameters are to be measured with
the FOT system and then normal ventilation is to be restored. Capnogram curves are going to
be recorded and respiratory mechanical parameters are going to be measured a) after
anaesthesia induction with the chest wall still intact, b) following chest wall opening
before CPB initiation, c) following CPB with the chest wall open and d) following sternal
closure before end of surgery in all groups of patients. Arterial and venous blood gas
samples are also going to be collected at these time points.
Sample sizes are estimated to enable the detection of a 15% difference in the primary outcome
parameter, the lung tissue elastance. Accordingly, sample-size estimation based on an ANOVA
test with two groups of patients indicated that 155 patients were required in each group to
detect a significant difference between the protocol groups (the assumed variability of 30%,
power of 80% and the significance level of 5%).
Two-way repeated measures ANOVA with the inclusion of an interaction term is used for all
measured variables with the protocol stage as within-subject factor (protocol stages) and
group allocation as between-subject factor to establish the effects of T2DM and the surgical
procedure on the measured respiratory mechanical and capnography indices. At half-way of the
data collection, an interim analyses will be performed and the further data collection will
be proceeded based on the results of this analysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |